Owkin
David Vallas currently serves as VP Legal and Head of Data Access & Privacy at Owkin, a position held since January 2019, after previously acting as Legal Director at the same company. Responsibilities include managing data privacy and compliance, contract negotiations with academic and private partners for AI projects, and overseeing IT and consultancy contracts related to the MOSAIC Study. Prior experience includes Senior Legal Counsel at Owkin, a Juriste role at Institut Curie, and positions at Institut Pasteur, LOCAM, and various law firms as a trainee. David Vallas holds a Master 2 degree in Applied Business Law to the Health Industries from Université Jean Monnet Saint-Etienne, earned between 2006 and 2011.
Previous companies
This person is not in any teams
This person is not in any offices
Owkin
6 followers
Owkin believes that medical research should be collaborative, inclusive, and privacy-preserving. Today, Owkin is pioneering AI in healthcare. It leverages its collaborative federated learning software and expert AI capabilities to bring solutions to optimize drug development and improve patient care in oncology. Owkin’s work has been published in Nature Medicine and other top-tier journals. Owkin has raised over $70M from leading VC funds and is now working with the most prominent cancer centers and pharmaceutical companies in Europe and the US. Additionally, Owkin leads several federated learning consortia, including; MELLODDY, to facilitate 'co-opetive' drug discovery between pharma companies, and Healthchain, to allow collaborative research across multiple hospitals. Owkin was co-founded in 2016 by Thomas Clozel, MD, a clinical research doctor and former assistant professor in clinical hematology, and by Gilles Wainrib, Ph.D., an academic pioneer in the field of Artificial Intelligence in biology.